MONT-SAINT-HILAIRE, QUEBEC -- (MARKET WIRE) -- December 12, 2006 -- In conjunction with its Analyst and Investor Presentation, Axcan Pharma Inc. (TSX: AXP)(NASDAQ: AXCA) today announced its growth strategy for the next 12 months. As part of its presentation, the Company detailed specific initiatives for growth through further leveraging its base business, a focused strategic direction for licensing and/or acquisitions, a targeted research and development pipeline and international expansion. In addition, the Company disclosed its revenue guidance for fiscal 2007.
